Background: Reactive oxygen species have been identified as mediators of cell injury in a variety of cardiovascular complications including Myocardial Infarction (MI). It is conceivable that vitamin E supplementation can be used therapeutically due to its role in ameliorating antioxidant status and free radicals scavenging activity.
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Biomolecular deterioration caused by reactive oxygen species including those associated with altered plasma antioxidant reserve and lipid peroxidation are now accepted to be related with a wide range of pathological processes including cardiovascular disease, cancer, rheumatoid arthritis and aging process etc. 1 . Increasing interest has been focused on the role of oxidative stress in the etiopathogenesis of Myocardial infarction (MI), which are convincingly linked to the altered antioxidant defense system and major interrelated derangements of cell metabolism including DNA strand breakage, damage to membrane ion transporters, specific proteins and lipid peroxidation. 2 Most common radical and non radical derivatives of oxygen includes superoxide free radical anion (O 2 ) produces highly toxic hydroxyl radical or produces hypochlorous acid (HOCl) by the action of enzyme myeloperoxidase in neutrophils and macrophages which amplify further destruction leading to cardiovascular disease (CVD). 3 Prime targets of these free radicals attack are the PUFA in the membrane lipids causing lipid peroxidation which initiates a complex cascade of events in arterial wall and thereby leads to the development of Atherosclerotic plaques followed by myocardial infarction. 4 These free radicals are efficiently removed by antioxidant defense system which includes antioxidant enzymes and antioxidants. Among various antioxidant enzymes, Glutathione peroxidase (GSHPx) is selenium containing enzyme and catalyses the decomposition of H 2 O 2 with the help of reduced glutathione. It also prevents the oxidation of lipids and phospholipids.
INTRODUCTION

MATERIALS AND METHODS
preventing the cascade leading to the development of MI. It has been shown previously that these nonenzymic antioxidants contribute significantly in scavenging free radicals, inhibiting lipid peroxidation, in repairing endothelial cells and restoring endothelium derived vasodilators etc. 6, 7 . Conversely, their role as proxidant and relation of uric acid with vascular injuries reflect the need of further investigation. 8, 9 It is conceivable that vitamin E, mainly α-tocopherol, can ameliorate the modifiable indexes via regulating the free radical production. Previous epidemiological studies and in our recent study on vitamin E supplementation have been found to reduce risk of CVD and age related complications. 10, 11, 12 However, outcomes of several clinical trials of cardioprotective effect of vitamin E have been proved disappointing and need further investigation. 13, 14 Therefore, the overall objectives of present study were to investigate the effect of in-vitro vitamin E supplementation in ameliorating the altered levels of plasma antioxidants (vitamin E, C, & A; and uric acid), erythrocyte GSHPx and lipid peroxidation (via MDA estimation) in the blood samples of MI patients.
In the present study, 60 patients who were diagnosed clinically and angiographically as MI patients (30- Plasma antioxidants, erythrocyte GSHPx and MDA levels were estimated in MI subjects before (non supplemented group i.e. Group I) and after 2 hours of vitamin E supplementation in-vitro (40 μg/ml of blood at 37
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• C; Group II) and compared it with that of healthy controls. Erythrocyte GSHPx and MDA levels (marker of lipid peroxidation) were estimated by Beutler's method and Sinnhuber et al method spectrophotometrically, after preparation of hemolysate. 15, 16 Plasma vitamin C, E & A, and uric acid levels were estimated by Mc Cormick and Greene method, Hashim and Shuttringer method, Sinha's method and Caraway's method respectively. [17] [18] [19] [20] Values were expressed as Mean ± SD. The significance of mean difference between groups was compared by using Student's t-test and distribution of probability (P) Biomolecular deterioration caused by reactive oxygen species including those associated with altered plasma antioxidant reserve and lipid peroxidation are now accepted to be related with a wide range of pathological processes including cardiovascular disease, cancer, rheumatoid arthritis and aging process etc. 1 . Increasing interest has been focused on the role of oxidative stress in the etiopathogenesis of Myocardial infarction (MI), which are cona Several evidences have been documented regarding enhanced production of ROS as well as for a decrease in the antioxidant reserve in plasma and tissues of MI patients. 2 Theoretically, it is conceivable that the exogenous administration of nonenzymic antioxidants such as vitamin E may prevent the development of cardiovascular diseases although contradictory evidences have been documented. 13 In this context, an attempt is made to control oxidative stress in MI by exogenous vitamin E supplementation. Among various free radicals, superoxide anion, efficiently removed by SOD [as reported in our previous study], 11 significantly participate in the etiopathogenesis of MI not only by inducing structural and functional damage to endothelial cells and vascular smooth muscle cells but also by producing H 2 O 2 which amplify further destruction via OH
• and HOCl formation. In addition to catalase, GSHPx plays a crucial role in the final detoxification of H 2 O 2. It spontaneously reacts with and scavenges many forms of ROS, prevents oxidation of lipids and phospholipids, maintains intracellular redox milieu, replenishes a number of crucial antioxidants (vitamin E and C) and produces vasodilatory prostacyclin by the endothelium. 1 In the present study, low GSHPx activities were observed in Group I subjects as compared to healthy controls which focused the role of GSHPx not only in the scavenging of H 2 O 2 but also in the prevention of progressive deterioration of endothelial cells (via. lipid peroxidation) initiated by highly reactive hydroxyl radical (OH .
). Kumar and Biswas also observed that erythrocyte antioxidant enzymes activity of RBC including GSHPx had decreased due to augmented oxidative stress in acute myocardial infarction subjects. 21 Reduced levels of free radical scavengers such as vitamin E, glutathione and SOD have been reported in MI patients by Bhargava et al. and suggested it as a result of their consumption during In the present study, the mean blood pressure and anthropometric indices of the study group subjects are depicted in Table 1 . The observations made reveal significant changes in antioxidant status and MDA levels in study group subjects before and after in-vitro vitamin E supplementation, as represented in Table 2 and 3. Erythrocyte GSHPx activity was significantly low (37.02 %; p<0.001) in MI subjects as compared to healthy controls that was found to be increase significantly (26.5%; p<0.05) on vitamin E supplementation. Plasma vitamin C, E & A levels were found to be significantly low in MI subjects (p<0.001, p<0.05; 58.6%, 48.7% and 31.25% low respectively). On in-vitro vitamin E supplementation, marked amelioration in plasma antioxidant vitamin levels were observed (p<0.001, p<0.05). Similarly, marked elevated levels of malondialdehyde (MDA) and plasma uric acid were observed in Group I (p<0.001; 52.8 % & 79.1 % high respectively) as compared to healthy controls .However, only MDA level was found to be decreased significantly (p<0.001; 32.0 %) in Group II whereas plasma uric acid levels decreased insignificantly (p<0.1; 8.2 % low) in Group II as compared to Group I. Where, p<0.05: Significant; p<0.001: Highly significant metabolism of oxygen free radicals. 22 On in-vitro vitamin E supplementation, significant increase in GSHPx activity (p<0.05) was observed in MI blood samples which could be explained as a glutathione sparing action of vitamin E by inhibiting lipid peroxidation and thereby replenishes GSHPx activity. 23 Consisting findings were reported by Garg et al in their studies on vitamin E supplementation on diabetic rats. 24 However, Li et.al observed no any effect of vitamin E supplementation on GSHPx activity. 13 Above mentioned observation is well supported by marked reduction in MDA levels (p<0.001) in supplemented samples which was 63.20 % high in Group I subjects. These findings clarify the chain breaking antioxidant property of vitamin E by which it protects the membrane bound lipids and nascent LDL against free radical mediated lipid peroxidation and thus plays a significant role in the reduction of MI. Furthermore, Chan observed that vitamin E administration retards LDL oxidation, inhibits smooth muscle proliferation, synthesis of leukotrienes, platelets adhesion, aggregation and expression. 24 It also potentiates the release of prostacyclin through upregulation of cytosolic phospholipase A 2 and cyclooxygnase .
In addition to antioxidant enzymes, free radicals are efficiently removed by co-operative action of other widely recognized non enzymatic antioxidants such as vitamin C, E & A, and uric acid. Vitamin C, an exogenous water soluble antioxidant functions as primary defense against free radicals in plasma and disappeared more quickly. It has a significant role in protecting plasma lipids against peroxidation (i.e. anti atherosclerotic effect) and positive correlation with HDL-cholestrerol. 6 Another possible mechanisms through which ascorbate plays a significant role in reducing MI includes its protective effect on Na + -K + ATPase against peroxidative damage and thereby in maintaining electrolyte balance enhancement of NO bioavailability and synergistic where, p<0.05: Significant; p<0.001: Highly significant; p<0.1:Non-significant action to regenerate α-tocopherol and urate from their radicals.
26-28
Vitamin E, a universal lipophilic, chain breaking antioxidant and a stabilizer of biological membranes, prevents accumulation of free radicals and decreases lipid peroxidation. Vitamin E quenches and reacts with superoxide anion, hydroxyl and peroxyl radical to provide protection against oxidative stress; and increases NO bioavailability. 29 In addition, β-carotene, mainly carried on LDL particle, is also an important fat soluble antioxidant that can quench singlet oxygen, competitively spares selenium in metabolic reactions, inhibits LDL oxidation; and is responsible for immune response, epithelial growth and repair. 30 Alteration in their levels may have a significant role in the development of MI.
In the present study, plasma levels of these antioxidant vitamins (C, E & A) were significantly low (p<0.001, p<0.001, p<0.05) in Group I as compared to control. Decreased levels of these vitamins could not be only due to their free radical scavenging action but also in maintaining the body antioxidant reserve and in normalization of vascular superoxide formation. Pahwa and Seth also observed reduction in antioxidant vitamin levels with increased levels of lipid peroxides in MI subjects and concluded it as a contributory event in the development of CVD. 31 Ugle et al also observed a marked reduction in vitamin A levels in CVD patients with smoking habit and suggested that CVD events can be prevented by improving the blood beta carotene and LDL-beta carotene status. 32 Despite data linking antioxidant role of these vitamins, their pro-oxidant properties also play a controversial role. 33 On in-vitro vitamin E supplementation, these levels were increased significantly in Group II (p<0.05; Table 3 ) as compared to Group I subjects. Our findings were in agreement with those of Prasad et al who observed that α-tocopherol treatment increases antioxidant reserves and cardiac contractility. 34 However, Keith et al. found no any significant effect of vitamin E supplementation on other marker of oxidative stress. 35 The increased concentration of vitamin C, E and A, as observed in the present study may be linked to a series of reactions which include synergistic action of vitamin C, E and A (Fig 1.0) i.e. inhibition of lipid peroxidation by lipid peroxyl radical scavenging action of vitamin C and A to produce their radicals. α-tocopherol regenerates vitamin C and A from their radical forms by reducing them and itself being converted into α-tocopheroxyl radical. 36 In addition, erythrocytes and neutrophils take up ascorbate radicals rapidly and convert it back to ascorbate at the expense of GSHPx and in presence of Glutathione-semidehydro ascorbate reductase enzyme.
6 Furthermore, increased vitamin E level could also be explained on the basis of its direct association with vitamin E supplementation. 35 Moreover, uric acid is an endogenous, preventive and chain breaking antioxidant which contributes about 65% of free radical scavenging action, stabilizes ascorbate, protects DNA and erythrocytes from oxidative damage. 7 Increased production of superoxide anion reduces NO bioavailability by reacting with NO to form toxic product peroxynitrite anion (ONOO 
29
Plasma uric acid interacts with peroxynitrite anion to form a stable nitric oxide donor, thus promoting vasodilation and restores endothelial function. 37 In the present study, plasma uric acid levels were found to be significantly high (p<0.001) in MI subjects and were in agreement with the findings of Pahwa and Seth which indicates that body is trying to protect itself from the deleterious effects of free radicals by increasing uric acid production. 31 According to Maxwell and Bruinsma, elevation of uric acid production is a secondary event and occur due to disinhibition of xanthine oxidase activity via reduction in vascular NO activity because NO is known to interact with active site of xanthine oxidase and inhibits its activity to produce uric acid. 38 However, on in-vitro vitamin E supplementation, insignificant reduction in plasma uric acid was observed in Group II (p<0.1) which may be due to limitation of present study (i.e. in-vitro study), as it is well supported by the fact that uric acid synthesis and the enzymes concerned with its metabolism are present in liver. Therefore, further study is warranted to shed more light on the hidden facts related to therapeutic use of antioxidants.
On the basis of present findings and consistent findings of previous studies, it can be inferred that oxidative stress plays a crucial role in MI and vitamin E supplementation provide protection against oxidative stress not only by their free radical scavenging action but also by ameliorating antioxidant reserve and by preventing biomolecular deterioration (lipid peroxidation) which are responsible for MI development. Therefore, consumption of diet rich in vitamin E should be increased with suspection of disease, which may prevent or postpone the development of MI.
CONCLUSION
